EG22337A - Process for preparing novel pharmaceutical compounds - Google Patents

Process for preparing novel pharmaceutical compounds

Info

Publication number: EG22337A
Authority: EG; Egypt
Prior art keywords: pharmaceutical compounds; novel pharmaceutical; preparing novel; preparing; compounds
Prior art date: 1997-12-16

Application number

EG155698A

Other languages

English (en)

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-12-16

Filing date

1998-12-15

Publication date

2002-12-31

1998-12-15 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2002-12-31 Application granted granted Critical

2002-12-31 Publication of EG22337A publication Critical patent/EG22337A/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Diabetes (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Obesity (AREA)
Hematology (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

EG155698A 1997-12-16 1998-12-15 Process for preparing novel pharmaceutical compounds EG22337A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9726566.4A GB9726566D0 (en)	1997-12-16	1997-12-16	Novel pharmaceutical

Publications (1)

Publication Number	Publication Date
EG22337A true EG22337A (en)	2002-12-31

Family

ID=10823692

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EG155698A EG22337A (en)	1997-12-16	1998-12-15	Process for preparing novel pharmaceutical compounds

Country Status (35)

Country	Link
EP (2)	EP1040110A1 (xx)
JP (1)	JP2002508373A (xx)
KR (1)	KR100549142B1 (xx)
CN (3)	CN101381367A (xx)
AP (1)	AP1365A (xx)
AR (1)	AR017214A1 (xx)
AU (1)	AU1967999A (xx)
BG (1)	BG64988B1 (xx)
BR (1)	BR9813600A (xx)
CA (1)	CA2314107A1 (xx)
CO (1)	CO4980880A1 (xx)
CZ (1)	CZ299965B6 (xx)
DZ (1)	DZ2681A1 (xx)
EA (1)	EA004260B1 (xx)
EG (1)	EG22337A (xx)
GB (1)	GB9726566D0 (xx)
HR (1)	HRP20000408B1 (xx)
HU (1)	HUP0100509A3 (xx)
IL (1)	IL136424A (xx)
IN (1)	IN192487B (xx)
MA (1)	MA26580A1 (xx)
MY (1)	MY135612A (xx)
NO (1)	NO317254B1 (xx)
OA (1)	OA11766A (xx)
PE (1)	PE20000058A1 (xx)
PL (1)	PL341146A1 (xx)
RS (1)	RS50126B (xx)
SA (1)	SA99191115B1 (xx)
SK (1)	SK286618B6 (xx)
TR (2)	TR200001799T2 (xx)
TW (1)	TW509690B (xx)
UA (1)	UA72198C2 (xx)
UY (2)	UY25304A1 (xx)
WO (1)	WO1999031095A1 (xx)
ZA (1)	ZA9811506B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9726568D0 (en)	1997-12-16	1998-02-11	Smithkline Beecham Plc	Novel pharmaceutical
US6664278B2 (en)	1997-12-16	2003-12-16	Smithkline Beecham P.L.C.	Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
GB9909041D0 (en) *	1999-04-20	1999-06-16	Smithkline Beecham Plc	Novel pharmaceutical
KR100744359B1 (ko) *	1999-04-23	2007-07-30	스미스클라인비이참피이엘시이	티아졸리딘디온 유도체 및 항당뇨병제로서 그의 용도
TR200103060T2 (tr) *	1999-04-23	2002-05-21	Smithkline Beecham P. L. C.	Yeni farmasötik maddeler
ATE246191T1 (de) *	1999-04-23	2003-08-15	Smithkline Beecham Plc	Polymorph von 5-(4-(2-(n-methyl-n-(2- pyrdyl)amino)äthoxy)benzyl)thiazolidin-2,4-dion maleinsäuresalz
WO2001081327A1 (fr)	2000-04-25	2001-11-01	Kyorin Pharmaceutical Co., Ltd.	Nouveau cristal stable de derive thiazolidinedione et son procede de production
GB0014005D0 (en) *	2000-06-08	2000-08-02	Smithkline Beecham Plc	Novel pharmaceutical
GB0021784D0 (en) *	2000-09-05	2000-10-18	Smithkline Beecham Plc	Novel pharmaceutical
GB0021978D0 (en) *	2000-09-07	2000-10-25	Smithkline Beecham Plc	Novel pharmaceutical
CA2426117A1 (en) *	2000-09-26	2002-04-04	Dr. Reddy's Research Foundation	Novel polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation
WO2003050112A1 (en) *	2001-12-13	2003-06-19	Smithkline Beecham Plc	Toluenesulfonate hydrates of a thiazolidinedione derivative
GB0129876D0 (en) *	2001-12-13	2002-02-06	Smithkline Beecham Plc	Novel pharmaceutical
GB0129872D0 (en) *	2001-12-13	2002-02-06	Smithkline Beecham Plc	Novel pharmaceutical
GB2405403A (en) *	2003-08-29	2005-03-02	Cipla Ltd	Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
ITMI20041537A1 (it) *	2004-07-28	2004-10-28	Chemi Spa	Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) *	2005-05-24	2007-09-26	Zentiva, A. S.	Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
EP2184055A1 (en)	2008-11-07	2010-05-12	LEK Pharmaceuticals d.d.	Process for preparing solid dosage forms of rosiglitazone maleate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3856378T2 (de) *	1987-09-04	2000-05-11	Beecham Group Plc	Substituierte Thiazolidindionderivate
GB8820389D0 (en) *	1988-08-26	1988-09-28	Beecham Group Plc	Novel compounds
GB9218830D0 (en) *	1992-09-05	1992-10-21	Smithkline Beecham Plc	Novel compounds
SG47100A1 (en) *	1994-02-10	1998-03-20	Smithkline Beecham Plc	Use of insulin sensitisers for treating renal diseases

1997
- 1997-12-16 GB GBGB9726566.4A patent/GB9726566D0/en not_active Ceased
1998
- 1998-12-14 KR KR1020007006515A patent/KR100549142B1/ko not_active IP Right Cessation
- 1998-12-14 TR TR2000/01799T patent/TR200001799T2/xx unknown
- 1998-12-14 CA CA002314107A patent/CA2314107A1/en not_active Abandoned
- 1998-12-14 MA MA25389A patent/MA26580A1/fr unknown
- 1998-12-14 CN CNA200810087031XA patent/CN101381367A/zh active Pending
- 1998-12-14 JP JP2000539019A patent/JP2002508373A/ja not_active Withdrawn
- 1998-12-14 AU AU19679/99A patent/AU1967999A/en not_active Abandoned
- 1998-12-14 IL IL13642498A patent/IL136424A/xx unknown
- 1998-12-14 CZ CZ20002204A patent/CZ299965B6/cs not_active IP Right Cessation
- 1998-12-14 OA OA1200000178A patent/OA11766A/en unknown
- 1998-12-14 RS YUP-363/00A patent/RS50126B/sr unknown
- 1998-12-14 EP EP98964510A patent/EP1040110A1/en not_active Withdrawn
- 1998-12-14 WO PCT/EP1998/008155 patent/WO1999031095A1/en active IP Right Grant
- 1998-12-14 EP EP05077331A patent/EP1661895A1/en not_active Withdrawn
- 1998-12-14 HU HU0100509A patent/HUP0100509A3/hu unknown
- 1998-12-14 PL PL98341146A patent/PL341146A1/xx not_active Application Discontinuation
- 1998-12-14 SK SK917-2000A patent/SK286618B6/sk not_active IP Right Cessation
- 1998-12-14 CN CN98812089A patent/CN1281453A/zh active Pending
- 1998-12-14 CN CNA2008100870305A patent/CN101302215A/zh active Pending
- 1998-12-14 AP APAP/P/2000/001831A patent/AP1365A/en active
- 1998-12-14 UA UA2000063485A patent/UA72198C2/uk unknown
- 1998-12-14 EA EA200000654A patent/EA004260B1/ru not_active IP Right Cessation
- 1998-12-14 BR BR9813600-3A patent/BR9813600A/pt not_active Application Discontinuation
- 1998-12-15 UY UY25304A patent/UY25304A1/es unknown
- 1998-12-15 ZA ZA9811506A patent/ZA9811506B/xx unknown
- 1998-12-15 MY MYPI98005674A patent/MY135612A/en unknown
- 1998-12-15 EG EG155698A patent/EG22337A/xx active
- 1998-12-15 DZ DZ980291A patent/DZ2681A1/xx active
- 1998-12-15 AR ARP980106370A patent/AR017214A1/es unknown
- 1998-12-15 UY UY25308A patent/UY25308A1/es not_active IP Right Cessation
- 1998-12-16 TR TR1998/02625A patent/TR199802625A3/tr unknown
- 1998-12-16 CO CO98074834A patent/CO4980880A1/es unknown
- 1998-12-16 IN IN3772DE1998 patent/IN192487B/en unknown
- 1998-12-16 PE PE1998001233A patent/PE20000058A1/es not_active Application Discontinuation
- 1998-12-16 TW TW087121121A patent/TW509690B/zh not_active IP Right Cessation
1999
- 1999-02-27 SA SA99191115A patent/SA99191115B1/ar unknown
2000
- 2000-06-15 NO NO20003069A patent/NO317254B1/no not_active IP Right Cessation
- 2000-06-16 HR HR20000408A patent/HRP20000408B1/xx not_active IP Right Cessation
- 2000-07-13 BG BG104603A patent/BG64988B1/bg unknown

Also Published As

Publication number	Publication date
NO317254B1 (no)	2004-09-27
BR9813600A (pt)	2000-10-10
KR100549142B1 (ko)	2006-02-03
CN101302215A (zh)	2008-11-12
SK286618B6 (sk)	2009-02-05
CN1281453A (zh)	2001-01-24
IN192487B (xx)	2004-04-24
NO20003069L (no)	2000-06-15
EA004260B1 (ru)	2004-02-26
BG64988B1 (bg)	2006-11-30
OA11766A (en)	2005-07-19
GB9726566D0 (en)	1998-02-11
HUP0100509A3 (en)	2002-06-28
TR199802625A2 (xx)	1999-10-21
CN101381367A (zh)	2009-03-11
TW509690B (en)	2002-11-11
AR017214A1 (es)	2001-08-22
TR199802625A3 (tr)	1999-10-21
PE20000058A1 (es)	2000-02-26
SK9172000A3 (en)	2001-01-18
PL341146A1 (en)	2001-03-26
IL136424A0 (en)	2001-06-14
UY25304A1 (es)	2000-12-29
MY135612A (en)	2008-05-30
HRP20000408B1 (en)	2008-04-30
WO1999031095A1 (en)	1999-06-24
BG104603A (en)	2001-03-30
RS50126B (sr)	2009-03-25
TR200001799T2 (tr)	2001-01-22
YU36300A (sh)	2004-03-12
AP1365A (en)	2005-01-26
UA72198C2 (en)	2005-02-15
JP2002508373A (ja)	2002-03-19
CZ299965B6 (cs)	2009-01-07
ZA9811506B (en)	2000-11-06
HUP0100509A2 (hu)	2002-05-29
HRP20000408A2 (en)	2000-08-31
DZ2681A1 (fr)	2004-06-20
MA26580A1 (fr)	2004-12-20
EP1040110A1 (en)	2000-10-04
AP2000001831A0 (en)	2000-06-30
IL136424A (en)	2003-12-10
EP1661895A1 (en)	2006-05-31
CO4980880A1 (es)	2000-11-27
SA99191115B1 (ar)	2006-10-11
CA2314107A1 (en)	1999-06-24
AU1967999A (en)	1999-07-05
CZ20002204A3 (cs)	2000-11-15
KR20010033141A (ko)	2001-04-25
EA200000654A1 (ru)	2000-12-25
UY25308A1 (es)	1999-07-19
NO20003069D0 (no)	2000-06-15

Publication	Publication Date	Title
EG22337A (en)	2002-12-31	Process for preparing novel pharmaceutical compounds
CY2551B1 (en)	2008-07-02	Process for preparing eprosartan
CY2555B1 (en)	2008-07-02	Process for preparing eprosartan
HU9802180D0 (en)	1998-11-30	Process for producing pharmaceutical compositions
EP1026255A4 (en)	2003-05-28	PROCESS FOR THE PREPARATION OF XYLITOL
EP0908524A4 (en)	2002-02-20	METHOD FOR PRODUCING AN ALPHA-MONOGLUCOSYL HESPERIDINE-RICH SUBSTANCE
SG70092A1 (en)	2000-01-25	Process for preparing dialkylnaphthalene
IL133140A0 (en)	2001-03-19	Novel process for the preparation of 4-aryl-piperidines
IL134059A0 (en)	2001-04-30	Process for preparing aminoarylacetylenes
IL131205A0 (en)	2001-01-28	Process for preparing pharmaceutical compounds
EG22077A (en)	2002-07-31	Process for preparing 4-substituted-ih-indole-3 glyoxamides
EP1026254A4 (en)	2003-05-28	METHOD FOR PRODUCING XYLITOL
EP0688770A3 (en)	1996-03-06	Process for the preparation of hydroxyflavans compounds
EP0932601A4 (en)	2000-02-02	METHOD FOR PRODUCING PHARMACEUTICALS
IL126184A (en)	2001-03-19	Process for preparing pentafluoropentanol
EG21226A (en)	2001-03-31	Process for preparing of new pharmaceutical compound
IL133288A (en)	2003-05-29	Process for preparing 3-isochromanone
GB9810502D0 (en)	1998-07-15	Process for preparing distrylbiphenyl compounds
EP0694512A3 (de)	1997-03-19	Verfahren zur Herstellung von Hexafluor-C4-Verbindungen
HU9701137D0 (en)	1997-08-28	Process for producing pharmaceutical intermedier
IL125646A (en)	2000-11-21	Process for preparing N-pyruvyl-L-proline
GB9800066D0 (en)	1998-03-04	Process for preparing dibenzocycycloheptene compounds
AU7667598A (en)	1998-12-30	Process for preparing 3-isochromanome
AU8232098A (en)	1999-02-08	Process for preparing tri-aryl-alkylalkenes
IL128643A0 (en)	2000-01-31	Process to prepare pharmaceutical compounds